ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024
Dissemination of extensively drug-resistant NDM-producing
Abstract read
In one paragraph
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Conflict wounds and antimicrobial resistance: a systematic review on local antimicrobials to prevent infection after extremity open fracture.BMJ military health · 2026Pooled it
- Molecular Characterisation and Descriptive Analysis of Carbapenemase-Producing Enterobacterales: Striking Epidemiological Changes.Antibiotics (Basel, Switzerland) · 2026Article
- Emergence of New Delhi Metallo-β-Lactamase 14-Producing Klebsiella pneumoniae Sequence Type 147 Clone in Spain and Outbreak in the Canary Islands.Emerging infectious diseases · 2026Article
- International spread or local outbreak? Epidemiologic analyses of transmission patterns of NDM-1-producingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Article
- Genomic Characterization of NDM-1 ProducerAntibiotics (Basel, Switzerland) · 2025Article
- Healthcare professionals challenged by 14 distinct carbapenemase-producing micro-organisms in a war-injured Ukrainian patient.Infection · 2025Article
- Management and Prevention of Multidrug-Resistant Bacteria in War Casualties.Tropical medicine and infectious disease · 2025Review
- In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Review
- Evolving antimicrobial resistance of extensively drug-resistant Gram-negative severe infections associated with conflict wounds in Ukraine: an observational study.The Lancet regional health. Europe · 2025Article
- Cross-Sectional Assessment on Carbapenem-Resistant Gram-Negative Bacteria Isolated from Patients in Moldova.Microorganisms · 2025Article
- Carbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022-February 2023.Infectious diseases and therapy · 2025Article
- Challenges in Managing Multidrug-Resistant Infections Among Refugees: Clinical Experience During the Ukrainian War.European journal of case reports in internal medicine · 2025Article
- Import of global high-risk clones is the primary driver of carbapenemase-producingJournal of medical microbiology · 2025Article
- Genomic surveillance of multidrug-resistant organisms based on long-read sequencing.Genome medicine · 2024Article
- Genomic surveillance detects interregional spread of New Delhi metallo-beta-lactamase-1-producingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- 'Antimicrobial resistance is invisible. I am not.'Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors.
Sandra WitteveenCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Jörg B HansGerman National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Radosław IzdebskiDepartement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Henrik HasmanNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Ørjan SamuelsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Laurent DortetFrench National Reference Center for Antimicrobial Resistance, INSERM UMR 1184, Paris-Saclay University, Bicêtre Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
Yvonne PfeiferDivision of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
Niall DelappeUniversity of Galway, Galway, Ireland.
Jesús Oteo-IglesiasReference and Research Laboratory on Antibiotic Resistance of the National Center for Microbiology and CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Dorota ŻabickaDepartement of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland.
Martin CormicanUniversity of Galway, Galway, Ireland.
Mirco SandfortDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Felix ReichertDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Anna K PöntinenDepartment of Biostatistics, Faculty of Medicine, University of Oslo, Oslo, Norway.
Martin A FischerDivision of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
Nelianne VerkaikDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
María Pérez-VazquezReference and Research Laboratory on Antibiotic Resistance of the National Center for Microbiology and CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Niels PfennigwerthGerman National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Anette M HammerumNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Søren HallstrømNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Marta BiedrzyckaDepartement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Kati RäisänenDepartment of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.
Cornelia Ch WieldersCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Paweł UrbanowiczDepartement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Angela de HaanCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Karin WestmoDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Fabian LandmanCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Han Gj van der HeideCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Simon LansuCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Romy D ZwittinkCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Daan W NotermansCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Aneta GuzekDepartment of Laboratory Diagnostics, Section of Microbiology, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
Viacheslav KondratiukNational Pirogov Memorial University, Vinnytsia, Ukraine.
Aidyn SalmanovShupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Sebastian HallerDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Marius LinkeviciusEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Sören GatermannGerman National Reference Centre for Multidrug-Resistant Gram-Negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Anke KohlenbergEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Marek GniadkowskiDepartement of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Guido WernerDivision of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
Antoni Pa HendrickxCentre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundThe war in Ukraine led to migration of Ukrainian people. Early 2022, several European national surveillance systems detected multidrug-resistant (MDR) bacteria related to Ukrainian patients.AimTo investigate the genomic epidemiology of New Delhi metallo-β-lactamase (NDM)-producing
Indexed as
Anti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEnterobacteriaceae InfectionsMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsProvidenciaWhole Genome SequencingAdultAgedEuropeFemaleHumansMaleMiddle AgedAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesdisseminationNew Delhi metallo-β-lactamaseProvidencia stuartiiUkrainian patientswar
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.